Xu et al. demonstrated significantly higher expression of serum MASP-2 in patients with SLE along with MASP-2 gene polymorphism, compared to NHCs and other rheumatic diseases including rheumatoid arthritis, osteoarthritis, Sjogren's syndrome, and ankylosing spondylitis. Here, MASP2 is linked to rheumatic disorder.